Dai Dai, Shuangshuang Gu, Xiaxia Han, Huihua Ding, Yang Jiang, Xiaoou Zhang, Chao Yao, Soonmin Hong, Jinsong Zhang, Yiwei Shen, Guojun Hou, Bo Qu, Haibo Zhou, Yuting Qin, Yuke He, Jianyang Ma, Zhihua Yin, Zhizhong Ye, Jie Qian, Qian Jiang, Lihua Wu, Qiang Guo, Sheng Chen, Chuanxin Huang, Leah C. Kottyan, Matthew T. Weirauch, Carola G. Vinuesa, Nan Shen
{"title":"The transcription factor ZEB2 drives the formation of age-associated B cells","authors":"Dai Dai, Shuangshuang Gu, Xiaxia Han, Huihua Ding, Yang Jiang, Xiaoou Zhang, Chao Yao, Soonmin Hong, Jinsong Zhang, Yiwei Shen, Guojun Hou, Bo Qu, Haibo Zhou, Yuting Qin, Yuke He, Jianyang Ma, Zhihua Yin, Zhizhong Ye, Jie Qian, Qian Jiang, Lihua Wu, Qiang Guo, Sheng Chen, Chuanxin Huang, Leah C. Kottyan, Matthew T. Weirauch, Carola G. Vinuesa, Nan Shen","doi":"10.1126/science.adf8531","DOIUrl":null,"url":null,"abstract":"<div >Age-associated B cells (ABCs) accumulate during infection, aging, and autoimmunity, contributing to lupus pathogenesis. In this study, we screened for transcription factors driving ABC formation and found that zinc finger E-box binding homeobox 2 (ZEB2) is required for human and mouse ABC differentiation in vitro. ABCs are reduced in <i>ZEB2</i> haploinsufficient individuals and in mice lacking <i>Zeb2</i> in B cells. In mice with toll-like receptor 7 (TLR7)–driven lupus, ZEB2 is essential for ABC formation and autoimmune pathology. ZEB2 binds to +20-kb myocyte enhancer factor 2b (<i>Mef2b</i>)’s intronic enhancer, repressing MEF2B-mediated germinal center B cell differentiation and promoting ABC formation. ZEB2 also targets genes important for ABC specification and function, including <i>Itgax</i>. ZEB2-driven ABC differentiation requires JAK-STAT (Janus kinase-signal transducer and activator of transcription), and treatment with JAK1/3 inhibitor reduces ABC accumulation in autoimmune mice and patients. Thus, ZEB2 emerges as a driver of B cell autoimmunity.</div>","PeriodicalId":21678,"journal":{"name":"Science","volume":"383 6681","pages":""},"PeriodicalIF":44.7000,"publicationDate":"2024-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science","FirstCategoryId":"103","ListUrlMain":"https://www.science.org/doi/10.1126/science.adf8531","RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Age-associated B cells (ABCs) accumulate during infection, aging, and autoimmunity, contributing to lupus pathogenesis. In this study, we screened for transcription factors driving ABC formation and found that zinc finger E-box binding homeobox 2 (ZEB2) is required for human and mouse ABC differentiation in vitro. ABCs are reduced in ZEB2 haploinsufficient individuals and in mice lacking Zeb2 in B cells. In mice with toll-like receptor 7 (TLR7)–driven lupus, ZEB2 is essential for ABC formation and autoimmune pathology. ZEB2 binds to +20-kb myocyte enhancer factor 2b (Mef2b)’s intronic enhancer, repressing MEF2B-mediated germinal center B cell differentiation and promoting ABC formation. ZEB2 also targets genes important for ABC specification and function, including Itgax. ZEB2-driven ABC differentiation requires JAK-STAT (Janus kinase-signal transducer and activator of transcription), and treatment with JAK1/3 inhibitor reduces ABC accumulation in autoimmune mice and patients. Thus, ZEB2 emerges as a driver of B cell autoimmunity.
期刊介绍:
Science is a leading outlet for scientific news, commentary, and cutting-edge research. Through its print and online incarnations, Science reaches an estimated worldwide readership of more than one million. Science’s authorship is global too, and its articles consistently rank among the world's most cited research.
Science serves as a forum for discussion of important issues related to the advancement of science by publishing material on which a consensus has been reached as well as including the presentation of minority or conflicting points of view. Accordingly, all articles published in Science—including editorials, news and comment, and book reviews—are signed and reflect the individual views of the authors and not official points of view adopted by AAAS or the institutions with which the authors are affiliated.
Science seeks to publish those papers that are most influential in their fields or across fields and that will significantly advance scientific understanding. Selected papers should present novel and broadly important data, syntheses, or concepts. They should merit recognition by the wider scientific community and general public provided by publication in Science, beyond that provided by specialty journals. Science welcomes submissions from all fields of science and from any source. The editors are committed to the prompt evaluation and publication of submitted papers while upholding high standards that support reproducibility of published research. Science is published weekly; selected papers are published online ahead of print.